Publications by authors named "Simon F Lacey"

87Publications

Dual Targeting of Mesothelin and CD19 with Chimeric Antigen Receptor-Modified T Cells in Patients with Metastatic Pancreatic Cancer.

Mol Ther 2020 Jul 21. Epub 2020 Jul 21.

Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ymthe.2020.07.017DOI Listing
July 2020

First Trial of CRISPR-Edited T cells in Lung Cancer.

Trends Mol Med 2020 Aug 12;26(8):713-715. Epub 2020 Jun 12.

Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Parker Institute for Cancer Immunotherapy, University of Pennsylvania, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molmed.2020.06.001DOI Listing
August 2020

Systemic Endothelial Activation Is Associated With Early Acute Respiratory Distress Syndrome in Children With Extrapulmonary Sepsis.

Crit Care Med 2020 03;48(3):344-352

Department of Anesthesiology and Critical Care, Children's Hospital of Philadelphia, University of Pennsylvania, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCM.0000000000004091DOI Listing
March 2020

Establishing a model system for evaluating CAR T cell therapy using dogs with spontaneous diffuse large B cell lymphoma.

Oncoimmunology 2020 23;9(1):1676615. Epub 2019 Oct 23.

Department of Clinical Studies, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2019.1676615DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959441PMC
October 2019

Optimizing Chimeric Antigen Receptor T-Cell Therapy for Adults With Acute Lymphoblastic Leukemia.

J Clin Oncol 2020 02 9;38(5):415-422. Epub 2019 Dec 9.

Division of Hematology Oncology, Abramson Cancer Center, Cell Therapy and Transplant, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.19.01892DOI Listing
February 2020

Phase I Study of Lentiviral-Transduced Chimeric Antigen Receptor-Modified T Cells Recognizing Mesothelin in Advanced Solid Cancers.

Mol Ther 2019 11 30;27(11):1919-1929. Epub 2019 Jul 30.

Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15250016193032
Publisher Site
http://dx.doi.org/10.1016/j.ymthe.2019.07.015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838875PMC
November 2019

Dominant-Negative TGF-β Receptor Enhances PSMA-Targeted Human CAR T Cell Proliferation And Augments Prostate Cancer Eradication.

Mol Ther 2018 07 8;26(7):1855-1866. Epub 2018 May 8.

Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104-5156, USA; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104-5156, USA; Parker Institute for Cancer at the University of Pennsylvania, Philadelphia, PA 19104-5156, USA; Smilow Center for Translational Research, 3400 Civic Center Blvd., Philadelphia, PA 19104-5156, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15250016183020
Publisher Site
http://dx.doi.org/10.1016/j.ymthe.2018.05.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037129PMC
July 2018

Biomarkers in chimeric antigen receptor T-cell therapy.

Biomark Med 2018 05 26;12(5):415-418. Epub 2018 Apr 26.

Department of Pathology & Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
https://www.futuremedicine.com/doi/10.2217/bmm-2018-0054
Publisher Site
http://dx.doi.org/10.2217/bmm-2018-0054DOI Listing
May 2018

Activity of Mesothelin-Specific Chimeric Antigen Receptor T Cells Against Pancreatic Carcinoma Metastases in a Phase 1 Trial.

Gastroenterology 2018 07 20;155(1):29-32. Epub 2018 Mar 20.

Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2018.03.029DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035088PMC
July 2018

Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas.

N Engl J Med 2017 12 10;377(26):2545-2554. Epub 2017 Dec 10.

From the Lymphoma Program at the Abramson Cancer Center and the Division of Hematology-Oncology (S.J.S., J.S., E.A.C., S.D.N., A.R.M., D.L., D.L.P.), and the Department of Pathology and Laboratory Medicine (V.B., M.W., B.L.L., S.F.L., J.J.M., C.H.J.), Perelman School of Medicine, University of Pennsylvania, Philadelphia; Novartis Pharmaceuticals, Basel, Switzerland (Ö.A.); and Novartis Institutes for BioMedical Research, Cambridge, MA (J.L.B., I.P-M.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1708566
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1708566DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788566PMC
December 2017

Retroviral and Lentiviral Safety Analysis of Gene-Modified T Cell Products and Infused HIV and Oncology Patients.

Mol Ther 2018 01 20;26(1):269-279. Epub 2017 Oct 20.

Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA; Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ymthe.2017.10.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763152PMC
January 2018

PD-1 blockade modulates chimeric antigen receptor (CAR)-modified T cells: refueling the CAR.

Blood 2017 02 28;129(8):1039-1041. Epub 2016 Dec 28.

Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA; and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2016-09-738245DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5391777PMC
February 2017

Evaluating the skin in patients undergoing chimeric antigen receptor modified T-cell therapy.

J Am Acad Dermatol 2016 Nov;75(5):1054-1057

Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2016.06.062DOI Listing
November 2016

Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy for Acute Lymphoblastic Leukemia.

Crit Care Med 2017 Feb;45(2):e124-e131

1Division of Critical Care Medicine, Department of Anesthesia and Critical Care, The Children's Hospital of Philadelphia and The University of Pennsylvania Perelman School of Medicine, Philadelphia, PA. 2Division of Oncology, Department of Pediatrics, The Children's Hospital of Philadelphia and The University of Pennsylvania Perelman School of Medicine, Philadelphia, PA. 3Center for Cellular Immunotherapies, Department of Pathology and Laboratory Medicine, The University of Pennsylvania Perelman School of Medicine, Philadelphia, PA. 4Department of Biostatistics and Epidemiology, The University of Pennsylvania Perelman School of Medicine, Philadelphia, PA. 5Division of Hematology-Oncology, Department of Medicine, Abramson Cancer Center, The University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCM.0000000000002053DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5452983PMC
February 2017

Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic Leukemia.

Cancer Discov 2016 06 13;6(6):664-79. Epub 2016 Apr 13.

Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. Department of Pediatrics, The University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. Abramson Cancer Center, The University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. Department of Pathology and Laboratory Medicine, The University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-16-0040DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5448406PMC
June 2016

Measuring IL-6 and sIL-6R in serum from patients treated with tocilizumab and/or siltuximab following CAR T cell therapy.

J Immunol Methods 2016 07 3;434:1-8. Epub 2016 Apr 3.

University of Pennsylvania, Department of Pathology and Laboratory Medicine, Product Development & Correlative Sciences Laboratory, Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jim.2016.03.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5490247PMC
July 2016

Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy.

Cancer Discov 2015 Dec 29;5(12):1282-95. Epub 2015 Oct 29.

Division of Cancer Pathobiology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. Immunology Graduate Group, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. Cell & Molecular Biology Graduate Group, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. Department of Pathology & Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-15-1020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670800PMC
December 2015

Chimeric Antigen Receptor T Cells against CD19 for Multiple Myeloma.

N Engl J Med 2015 Sep;373(11):1040-7

From the Division of Hematology-Oncology, Department of Medicine (A.L.G., M.V.M., D.T.V., A.D.C., B.M.W., E.A.S.), Department of Biostatistics and Epidemiology (W.-T.H.), Department of Pathology and Laboratory Medicine (S.F.L., Y.D.M., J.J.M., Z.Z., A.B., B.L.L., C.H.J.), and Abramson Cancer Center (A.L.G., M.V.M., W.-T.H., S.F.L., Y.D.M., J.J.M., Z.Z., D.T.V., A.D.C., B.M.W., K.D., N.D.S.K., A.B., B.L.L., C.H.J., E.A.S.), Perelman School of Medicine, University of Pennsylvania, Philadelphia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1504542DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646711PMC
September 2015

Chimeric Antigen Receptor T Cells: Self-Replicating Drugs for Cancer.

Curr Drug Targets 2017 ;18(3):332-340

University of Pennsylvania, Department of Pathology and Laboratory Medicine, Center for Cellular Immunotherapies, Product Development & Correlative Sciences laboratory, 3400 Civic Center Boulevard, Philadelphia, PA 19104-5156, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1389450116666150825120427DOI Listing
September 2017

Chimeric antigen receptor T cells for sustained remissions in leukemia.

N Engl J Med 2014 Oct;371(16):1507-17

From the Division of Oncology, Children's Hospital of Philadelphia (S.L.M., R.A., D.M.B., N.J.B., S.R.R., D.T.T., S.A.G.), the Departments of Pediatrics (S.L.M., R.A., D.M.B., N.J.B., S.R.R., D.T.T., S.A.G.), Biostatistics and Epidemiology (P.A.S., R.A.), and Pathology and Laboratory Medicine (J.J.M., B.L.L., C.H.J., S.A.G.), the Division of Hematology-Oncology (N.F., D.L.P.), and Abramson Cancer Center (N.F., A.C., V.E.G., Z.Z., S.F.L., Y.D.M., J.J.M., B.L.L., C.H.J., D.L.P., S.A.G.), Perelman School of Medicine, University of Pennsylvania - all in Philadelphia; and Novartis Pharmaceuticals, East Hanover, NJ (A.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1407222DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4267531PMC
October 2014

Ex vivo detection of CD8 T cells specific for H-Y minor histocompatibility antigens in allogeneic hematopoietic stem cell transplant recipients.

Transpl Immunol 2014 May 26;30(4):128-35. Epub 2014 Feb 26.

Division of Translational Vaccine Research, City of Hope Comprehensive Cancer Center and Beckman Research Institute of the City of Hope, Duarte, CA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.trim.2014.02.001DOI Listing
May 2014

Biomarkers in T-cell therapy clinical trials.

Cytotherapy 2013 Jun 14;15(6):632-40. Epub 2013 Feb 14.

Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104-4283, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcyt.2013.01.002DOI Listing
June 2013

Recombinant modified vaccinia virus ankara (MVA) expressing wild-type human p53 induces specific antitumor CTL expansion.

Cancer Invest 2011 Oct 15;29(8):501-10. Epub 2011 Aug 15.

Division of Translational Vaccine Research, City of Hope National Medical Center, Duarte, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/07357907.2011.606248DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3260009PMC
October 2011

Development of infectious recombinant BK virus.

Virus Res 2011 Nov 4;161(2):150-61. Epub 2011 Aug 4.

Division of Translational Vaccine Research, Beckman Research Institute of the City of Hope, Duarte, CA 91010-3000, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.virusres.2011.07.017DOI Listing
November 2011

A phase I study in adults of clofarabine combined with high-dose melphalan as reduced-intensity conditioning for allogeneic transplantation.

Biol Blood Marrow Transplant 2012 Mar 27;18(3):432-40. Epub 2011 Jul 27.

Department of Hematology/Hematopoietic Cell Transplantation, City of Hope, Duarte, California 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2011.07.017DOI Listing
March 2012

Vaccine-induced control of viral shedding following rhesus cytomegalovirus challenge in rhesus macaques.

J Virol 2011 Mar 29;85(6):2878-90. Epub 2010 Dec 29.

California National Primate Research Center, University of California, Davis, County Rd. 98 and Hutchison Dr., Davis, CA 95616-8542, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/JVI.00883-10DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3067943PMC
March 2011

A comparative study of Merkel cell, BK and JC polyomavirus infections in renal transplant recipients and healthy subjects.

J Clin Virol 2010 Oct 27;49(2):137-40. Epub 2010 Jul 27.

Division of Translational Vaccine Research, Department of Virology, Beckman Research Institute of the City of Hope, Duarte, CA 91010-3000, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcv.2010.06.017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2943003PMC
October 2010

Programmed death-1 expression in liver transplant recipients as a prognostic indicator of cytomegalovirus disease.

J Infect Dis 2008 Jan;197(1):25-33

Laboratory of Vaccine Research, Beckman Research Institute of the City of Hope, City of Hope Comprehensive Cancer Center, Duarte, California 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1086/523652DOI Listing
January 2008

Functional characterization of BK virus-specific CD4+ T cells with cytotoxic potential in seropositive adults.

Viral Immunol 2007 Sep;20(3):379-88

Laboratory of Vaccine Research, Beckman Research Institute of the City of Hope, Duarte, CA 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/vim.2007.0030DOI Listing
September 2007

Low frequency of BK virus in prostatic adenocarcinomas.

APMIS 2007 Jun;115(6):743-9

Department of Pathology, Beckman Research Institute, City of Hope National Medical Center, Duarte, California 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-0463.2007.apm_601.xDOI Listing
June 2007

Oblimersen and alpha-interferon in metastatic renal cancer: a phase II study of the California Cancer Consortium.

J Cancer Res Clin Oncol 2007 Oct 17;133(10):705-11. Epub 2007 May 17.

Division of Medical Oncology, City of Hope National Medical Center, 1500 East Duarte Road, Duarte, CA 91010-3000, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-007-0200-6DOI Listing
October 2007

Functional comparison of T cells recognizing cytomegalovirus pp65 and intermediate-early antigen polypeptides in hematopoietic stem-cell transplant and solid organ transplant recipients.

J Infect Dis 2006 Nov 11;194(10):1410-21. Epub 2006 Oct 11.

Laboratory of Vaccine Research, Division of Information Sciences, Beckman Research Institute of the City of Hope, City of Hope Comprehensive Cancer Center, Duarte, CA 91010-3000, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1086/508495DOI Listing
November 2006

Cross-reactive CTL recognizing two HLA-A*02-restricted epitopes within the BK virus and JC virus VP1 polypeptides are frequent in immunocompetent individuals.

Virology 2006 Jun 5;350(1):128-36. Epub 2006 Apr 5.

Laboratory of Vaccine Research, Beckman Research Institute of the City of Hope, 1450 East Duarte Road, Duarte, CA 91010-3000, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.virol.2006.02.040DOI Listing
June 2006

In vitro expansion of polyclonal T-cell subsets for adoptive immunotherapy by recombinant modified vaccinia Ankara.

Exp Hematol 2006 Apr;34(4):497-507

Laboratory of Vaccine Research, Beckman Research Institute of the City of Hope, CA 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2005.12.018DOI Listing
April 2006

Attenuated poxvirus expressing three immunodominant CMV antigens as a vaccine strategy for CMV infection.

J Clin Virol 2006 Mar 4;35(3):324-31. Epub 2006 Jan 4.

Laboratory of Vaccine Research, Beckman Research Institute of the City of Hope, Duarte, CA 91010, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S138665320500313
Publisher Site
http://dx.doi.org/10.1016/j.jcv.2005.09.018DOI Listing
March 2006

Simultaneous reconstitution of multiple cytomegalovirus-specific CD8+ cell populations with divergent functionality in hematopoietic stem-cell transplant recipients.

J Infect Dis 2005 Mar 9;191(6):977-84. Epub 2005 Feb 9.

Laboratory of Vaccine Research, Beckman Research Institute of the City of Hope, Duarte, California 91010-3000, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1086/428136DOI Listing
March 2005

Characterization of host immunity to cytomegalovirus pp150 (UL32).

Hum Immunol 2005 Feb;66(2):116-26

Laboratory of Vaccine Research, Beckman Research Institute of the City of Hope, Duarte, CA 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humimm.2004.10.008DOI Listing
February 2005

Assessment of cellular immunity to human cytomegalovirus in recipients of allogeneic stem cell transplants.

Biol Blood Marrow Transplant 2004 Jul;10(7):433-47

Laboratory of Vaccine Research, Beckman Research Institute of the City of Hope, Duarte, California 91010-3000, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2003.12.004DOI Listing
July 2004

Attenuated poxviruses generate clinically relevant frequencies of CMV-specific T cells.

Blood 2004 Aug 15;104(3):847-56. Epub 2004 Apr 15.

Laboratory of Vaccine Research, Beckman Research Institute of the City of Hope,City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2003-10-34
Publisher Site
http://dx.doi.org/10.1182/blood-2003-10-3469DOI Listing
August 2004

Relevance of peptide avidity to the T cell receptor for cytomegalovirus-specific ex vivo CD8 T cell cytotoxicity.

J Infect Dis 2003 Sep 9;188(6):908-18. Epub 2003 Sep 9.

Beckman Research Institute of the City of Hope, Duarte, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1086/377582DOI Listing
September 2003

Preclinical development of an adjuvant-free peptide vaccine with activity against CMV pp65 in HLA transgenic mice.

Blood 2002 Nov 12;100(10):3681-9. Epub 2002 Jul 12.

Laboratory of Vaccine Research, Division of Virology, Beckman Research Institute of the City of Hope, Duarte, CA 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2002-03-0926DOI Listing
November 2002

Characterization of cytotoxic function of CMV-pp65-specific CD8+ T-lymphocytes identified by HLA tetramers in recipients and donors of stem-cell transplants.

Transplantation 2002 Sep;74(5):722-32

Laboratory of Vaccine Research, Division of Virology, Beckman Research Institute of the City of Hope, Duarte, California 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00007890-200209150-00023DOI Listing
September 2002